Search Browse Earnings

Innoviva, Inc.

Nasdaq:INVA

Pharmaceutical Preparations·BURLINGAME, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CFO

Basso Stephen

Revenue

$310.5M

-6.3% YoY

FY 2025

Adj. EBITDA

$127.8M

41.2% margin

FY 2025

Net Income

—

EPS (Diluted)

$2.20

FY 2025

Stock Price

$22.42

+0.0%

2026-03-11

52W Range

$16.52 – $25.14

P/E Ratio

10.2x

Market Cap

$1.7B

Cash

$305.0M

FY 2025

Total Debt

$448.3M

FY 2025

Net Debt

$143.4M

FY 2025

Enterprise Value

$1.8B

Debt / EBITDA

1.1x

FY 2025

EV / EBITDA

14.1x

Employees

—